Voya Financial Advisors’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-1,112
| Closed | -$683K | – | 235 |
|
|
2024
Q3 | $683K | Sell |
1,112
-140
| -11% | -$82.9K | 0.07% | 127 |
|
|
2024
Q2 | $690K | Sell |
1,252
-91
| -7% | -$52.1K | 0.08% | 120 |
|
|
2024
Q1 | $778K | Sell |
1,343
-155
| -10% | -$87K | 0.09% | 107 |
|
|
2023
Q4 | $798K | Sell |
1,498
-180
| -11% | -$87.1K | 0.1% | 101 |
|
|
2023
Q3 | $844K | Buy |
1,678
+67
| +4% | +$35.7K | 0.11% | 83 |
|
|
2023
Q2 | $829K | Sell |
1,611
-37
| -2% | -$20K | 0.1% | 89 |
|
|
2023
Q1 | $928K | Sell |
1,648
-406
| -20% | -$229K | 0.12% | 74 |
|
|
2022
Q4 | $1.14M | Buy |
2,054
+167
| +9% | +$88.5K | 0.15% | 58 |
|
|
2022
Q3 | $975K | Buy |
1,887
+100
| +6% | +$56K | 0.13% | 85 |
|
|
2022
Q2 | $958K | Sell |
1,787
-198
| -10% | -$109K | 0.12% | 85 |
|
|
2022
Q1 | $1.18M | Sell |
1,985
-150
| -7% | -$86.2K | 0.14% | 75 |
|
|
2021
Q4 | $1.42M | Sell |
2,135
-215
| -9% | -$134K | 0.16% | 66 |
|
|
2021
Q3 | $1.36M | Buy |
2,350
+115
| +5% | +$63.1K | 0.17% | 61 |
|
|
2021
Q2 | $1.14M | Sell |
2,235
-9,208
| -80% | -$4.34M | 0.15% | 74 |
|
|
2021
Q1 | $5.17M | Buy |
11,443
+1,408
| +14% | +$672K | 0.2% | 83 |
|
|
2020
Q4 | $4.63M | Buy |
10,035
+878
| +10% | +$412K | 0.2% | 81 |
|
|
2020
Q3 | $3.98M | Buy |
9,157
+193
| +2% | +$79.7K | 0.2% | 79 |
|
|
2020
Q2 | $3.14M | Buy |
8,964
+51
| +0.6% | +$17.1K | 0.17% | 97 |
|
|
2020
Q1 | $2.54M | Buy |
8,913
+964
| +12% | +$304K | 0.14% | 106 |
|
|
2019
Q4 | $2.58M | Buy |
7,949
+885
| +13% | +$268K | 0.13% | 128 |
|
|
2019
Q3 | $2.03M | Buy |
7,064
+207
| +3% | +$59.3K | 0.11% | 141 |
|
|
2019
Q2 | $2.01M | Buy |
6,857
+265
| +4% | +$73K | 0.11% | 145 |
|
|
2019
Q1 | $1.78M | Buy |
6,592
+962
| +17% | +$239K | 0.1% | 156 |
|
|
2018
Q4 | $1.25M | Buy |
5,630
+468
| +9% | +$110K | 0.08% | 177 |
|
|
2018
Q3 | $1.26M | Buy |
5,162
+1,771
| +52% | +$407K | 0.07% | 212 |
|
|
2018
Q2 | $697K | Sell |
3,391
-481
| -12% | -$102K | 0.05% | 264 |
|
|
2018
Q1 | $797K | Buy |
3,872
+89
| +2% | +$18.7K | 0.05% | 251 |
|
|
2017
Q4 | $723K | Buy |
3,783
+108
| +3% | +$20.7K | 0.05% | 274 |
|
|
2017
Q3 | $685K | Buy |
3,675
+178
| +5% | +$32.2K | 0.05% | 269 |
|
|
2017
Q2 | $608K | Buy |
3,497
+968
| +38% | +$163K | 0.04% | 274 |
|
|
2017
Q1 | $389K | Buy |
2,529
+538
| +27% | +$82.2K | 0.03% | 334 |
|
|
2016
Q4 | $282K | Sell |
1,991
-185
| -9% | -$27.3K | 0.02% | 371 |
|
|
2016
Q3 | $340K | Sell |
2,176
-532
| -20% | -$82K | 0.03% | 305 |
|
|
2016
Q2 | $393K | Buy |
2,708
+945
| +54% | +$139K | 0.05% | 257 |
|
|
2016
Q1 | $248K | Buy |
1,763
+11
| +0.6% | +$1.47K | 0.03% | 315 |
|
|
2015
Q4 | $250K | Buy |
1,752
+19
| +1% | +$2.53K | 0.04% | 289 |
|
|
2015
Q3 | $208K | Buy |
1,733
+72
| +4% | +$9.38K | 0.04% | 292 |
|
|
2015
Q2 | $215K | Sell |
1,661
-18
| -1% | -$2.35K | 0.04% | 292 |
|
|
2015
Q1 | $228K | Buy |
+1,679
| New | +$216K | 0.04% | 284 |
|
Other funds holding TMO
Voya Financial Advisors's TMO Position: Q4 2024 in Review
Voya Financial Advisors sold out of Thermo Fisher Scientific (TMO) in Q4 2024, closing a stake of 1,112 shares — an estimated $683K sold.
Voya Financial Advisors first reported a position in TMO in Q1 2015 and held it in 39 quarters. The position peaked at $5.17M in Q1 2021. 2,616 funds tracked by Wall St. Rank hold TMO as of Q4 2024.
- Voya Financial Advisors reported no remaining Thermo Fisher Scientific position as of Q4 2024 after selling out during the quarter.
- Voya Financial Advisors sold 1,112 Thermo Fisher Scientific shares in Q4 2024, an estimated $683K.
- Voya Financial Advisors first reported a position in Thermo Fisher Scientific in Q1 2015 and held it in 39 quarters.
- Voya Financial Advisors's Thermo Fisher Scientific position peaked at $5.17M in Q1 2021.
- 2,616 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q4 2024.
Based on Voya Financial Advisors's 13F filing for Q4 2024, filed 14 Feb 2025.